Metropolitan Life Insurance Co. NY grew its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 3.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,464 shares of the company’s stock after purchasing an additional 993 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Medidata Solutions were worth $2,776,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. World Asset Management Inc acquired a new stake in Medidata Solutions in the 2nd quarter worth $235,000. Zeke Capital Advisors LLC acquired a new stake in Medidata Solutions in the 2nd quarter worth $239,000. First Republic Investment Management Inc. acquired a new stake in Medidata Solutions in the 2nd quarter worth $242,000. Asset Management One Co. Ltd. grew its position in Medidata Solutions by 102.7% in the 1st quarter. Asset Management One Co. Ltd. now owns 3,948 shares of the company’s stock worth $248,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Zions Bancorporation acquired a new stake in Medidata Solutions in the 2nd quarter worth $274,000.
In related news, CFO Rouven Bergmann sold 3,000 shares of Medidata Solutions stock in a transaction dated Tuesday, June 19th. The shares were sold at an average price of $82.85, for a total transaction of $248,550.00. Following the completion of the transaction, the chief financial officer now directly owns 81,642 shares of the company’s stock, valued at approximately $6,764,039.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert Taylor sold 5,000 shares of Medidata Solutions stock in a transaction dated Tuesday, July 31st. The shares were sold at an average price of $73.05, for a total transaction of $365,250.00. Following the transaction, the director now directly owns 44,036 shares of the company’s stock, valued at $3,216,829.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,788 shares of company stock worth $2,574,487. 4.70% of the stock is owned by company insiders.
MDSO has been the topic of several research analyst reports. Deutsche Bank raised their price target on shares of Medidata Solutions from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Wednesday, June 13th. Needham & Company LLC raised their price target on shares of Medidata Solutions from $80.00 to $90.00 and gave the stock a “buy” rating in a research report on Wednesday, June 13th. ValuEngine upgraded shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 2nd. BidaskClub lowered shares of Medidata Solutions from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 26th. Finally, Deutsche Bank lifted their target price on shares of Medidata Solutions from $78.00 to $85.00 and gave the company a “buy” rating in a research report on Thursday, May 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $87.62.
Shares of Medidata Solutions stock opened at $80.53 on Monday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.16. Medidata Solutions Inc has a twelve month low of $59.60 and a twelve month high of $88.87. The stock has a market cap of $4.80 billion, a PE ratio of 94.74, a price-to-earnings-growth ratio of 5.04 and a beta of 1.45.
Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, July 24th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04. Medidata Solutions had a net margin of 9.13% and a return on equity of 11.37%. The business had revenue of $155.90 million for the quarter, compared to analyst estimates of $155.86 million. During the same period in the previous year, the business earned $0.31 EPS. The firm’s revenue was up 14.6% on a year-over-year basis. research analysts forecast that Medidata Solutions Inc will post 0.79 earnings per share for the current year.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Read More: Moving Average – How it Helps Investors in Stock Selection
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.